Tate & Lyle has said that it remains confident in its sucralose business despite the loss of its patent infringement case in the US.
A spokesperson for Tate & Lyle told just-food today (23 September) that the company believes it still holds a number of competitive advantages in the sucralose market, including superior technology and hygiene, years of experience in the market, the strength of the Splenda brand and good long-term relationships with key customers.
“Intellectual property is just one of a number of different layers of protection which define Tate & Lyle’s formidable competitive advantage in the global sucralose business,” Karl Kramer, president, Tate & Lyle Sucralose added.
Tate & Lyle declined to quantify the impact of the ruling on the Splenda business. However, Cazenove analyst Polly Barclay said that she does not expect the decision to have a near-term impact.
“It is disappointing news for Tate,” she wrote in an investor note. “While this news has no impact on our near-term forecasts, it once again highlights the risk of generic sucralose.”

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData